2 years on 0.5mg dutasteride, 5mg oral minoxidil 9/25/2026
Similar Community Posts Join
5 / 5 resultscommunity 3 months on 0,5 dutasteride and 2,5 oral minoxidil / 22 years
A 22-year-old experienced significant hair regrowth in three months using 0.5 mg dutasteride and 2.5 mg oral minoxidil, with no side effects. Users discussed the effectiveness of oral minoxidil, the necessity of dutasteride for maintaining hair, and concerns about potential side effects.
community 2 years on 0.5mg Dutasteride Minoxidil + Hair transplant 4000 Grafts
The user had a successful hair transplant with 4,000 grafts and uses 0.5 mg oral dutasteride and topical minoxidil to maintain results. They report minimal side effects and are pleased with the outcome.
community 1 month of progress 22M — Started 0.5mg Dutasteride and 2.5mg Oral Minoxidild
A 22-year-old started using 0.5mg Dutasteride and 2.5mg Oral Minoxidil for hair loss and noticed regrowth and darker hair after one month. They experienced lightheadedness initially due to overlapping doses but resolved it by taking the medication consistently.
community Progress after 5 months of 0.5 mg Dutasteride and 2.5 Mg oral minoxidil. I am considering a transplant eventually so strengthening the base area and doner areas. Suggestions on if I should continue the dosage for sometime before opting for a transplant or should I immediately go for it?
OP is using 0.5 mg Dutasteride and 2.5 mg oral Minoxidil for hair loss and considering a hair transplant. Most users suggest waiting 1-2 years to maximize results from the medication before opting for a transplant.
community Dutasteride 0.5 and oral minoxidil 2.5 for 3 months progress update
A 19-year-old shares progress on hair regrowth using dutasteride 0.5mg and oral minoxidil 2.5mg daily, reporting no side effects. Others discuss switching from finasteride to dutasteride and oral minoxidil for better results.
Related Research
6 / 6 resultsresearch Combination therapy with oral minoxidil and dutasteride in the treatment of male patterned baldness: A case report
This study found that combining oral minoxidil with dutasteride increased hair thickness, density, and new growth in male pattern baldness patients with minimal side effects.
research Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation
This pilot study found that among male androgenetic alopecia patients, 2.5 mg oral minoxidil with platelet-rich plasma led to higher patient satisfaction than 1.25 mg, though hair count improvements were not statistically significant.
research Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
In this correspondence, researchers reported that very-low-dose oral minoxidil (0.25 mg/d) showed some effectiveness in stabilizing trichoscopic parameters in male androgenetic alopecia. However, their analysis suggests that higher doses (2.5–5 mg/d) may lead to better clinical responses with similar rates of adverse events.
research Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
This study found that among various treatments for male androgenetic alopecia, dutasteride 0.5 mg/day was the most effective option overall. Additionally, among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy, and finasteride 1 mg/day was the most effective oral therapy.
research Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss
This review discusses the emerging evidence for low-dose oral minoxidil in treating various types of alopecia, without providing new clinical results.
research Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil
This study reports that low-dose oral minoxidil is generally well tolerated from a cardiovascular perspective, and serious side effects like pericardial effusion are associated with higher doses and pre-existing conditions.